Collaboration work continues, further new work in UK & NL
Collaboration work continues, further new work in UK
Collaboration work continues with small biotechs, EU & US pharma, EU chemistry providers & screening centers, new work with UK charities
Collaboration work continues with small biotechs, EU & US pharma, EU chemistry providers & EU screening centers
BioAxis Research has recieved subsidy funding for a project "Multi-Target Metabolic Syndrome Drugs" (STIMULUS funding, MKB Innovatiestimulering topsectoren Zuid-Nederland).
The 3D-e-Chem consortium, a team of chem- and bioinformatics researchers [CMBI (Radboudumc), Netherlands eScience Center, BioAxis Research, and Vrije Universiteit Amsterdam] have developed an open source virtual machine for computer-aided drug design. Described in a recent publication,
the computational building blocks (nodes) that enable researchers to design their own drug discovery workflows are now incorporated in KNIME, the leading open data analytics platform.
COILED collaboration funded by an EFRO grant begins
Collaboration work continues with small biotechs/large pharma/European screening centers
3D-e-Chem VM and Knime nodes updated
3d-e-Chem poster presented at Knime Spring Summit detailing progress on 3d-echem Virtual Machine and Knime nodes
Tel +31 (0)653589156
Visiting Address RK1332| Pivot Park Oss | Molenstraat 110 | 5342 AC | Oss | The Netherlands
Postal Address RK1332| Pivot Park Oss | Molenweg 79 | 5349 AC | Oss | The Netherlands
Strong Pharma Background in industry-leading cheminformatics and compound analysis. We help clients progress early stage discovery activities, working collaboratively to implement in silico drug design techniques, maximizing the potential of compounds to reach later development stages.
Our expertise covers:
Our success relies on secure professional collaboration, solid experience in pharmaceutical research and the most up-to-date computational tools.
A variety of applications are available covering Pharma and non-Pharma research. Our expertise ranges from industry leading commercially licensed molecular modelling suites, to open source workflow systems and relational databases.
Copyright © 2011-2020 All Rights Reserved